Clinical Trials in Dallas

Showing 13001-13020 of 17,468 trials

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172

Patients who have been diagnosed with clinically isolated syndrome (CIS) often develop problems related to the central nervous system, which controls the nerves in the body. Some of these patients may later be diagnosed with multiple sclerosis (MS), a progressive disease of the nervous system. The purpose of this study is to determine if the drug atorvastatin is helpful to CIS patients. Study hypothesis: Early intervention with atorvastatin in patients with CIS will result in a state of immunological tolerance.

Multiple Sclerosis

National Institute of Allergy and Infectious Diseases (NIAID)82 participantsStarted May 2005

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

NCT01644331

The primary objective of this study is to compare the effects of oral Tolvaptan vs. placebo as an adjunct to fixed dose IV furosemide on dyspnea relief in patients with acute decompensated heart failure The primary hypothesis is that the addition of oral Tolvaptan to fixed dose furosemide will be more effective at relieving dyspnea than fixed dose furosemide alone

Heart FailureDyspnea

Duke University257 participantsStarted Oct 2012

Aurora, Colorado, United States • Atlanta, Georgia, United States • Gainesville, Georgia, United States +15 more locations

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Find Trials by Condition in Dallas

A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)

Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes

Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)